Core Insights - IBA and Shreeji have signed a multi-site agreement for the delivery and installation of four Cyclone KIUBE 300 cyclotrons, valued at €5–7 million, to enhance PET radiopharmaceutical production in India [1][2][4] Company Overview - IBA is a global leader in particle accelerator technology, specializing in proton therapy, industrial sterilization, radiopharmaceuticals, and dosimetry, with approximately 2,100 employees worldwide [6] - Shreeji Imaging and Diagnostic Centre Pvt. Ltd. is a prominent Indian manufacturer and distributor of FDG and PET radiopharmaceuticals, operating the largest PET radiopharmacy network in India [7] Industry Context - The PET imaging market in India is rapidly expanding, with increasing access beyond major cities, leading to heightened demand for secure tracer supply [2] - The addition of Cyclone KIUBE 300 cyclotrons will enhance local manufacturing capabilities, reduce logistics risks, and support the production of new tracers [2][3] Strategic Implications - The partnership aims to improve patient access to PET diagnostics in cancer care by establishing a resilient, multi-node network for reliable supply [4] - The deployment of the Cyclone KIUBE systems is expected to stimulate latent PET demand and support the introduction of next-generation tracers [4]